Search

everythinglearnresearchcommunity

for

Search:↓

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Hair loss needs more research for better treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Hormones and genes affect hair growth and male baldness.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

New compounds show promise as nonsteroidal treatments for hair loss.

Minoxidil can reduce functions related to androgen receptors.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.